Company intelligence / Profile preview

ExSight Ventures

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

ExSight Ventures is a returns-oriented, mission-focused venture capital firm specializing in early-stage investments in innovative ophthalmic diagnostic and treatment solutions. It addresses funding gaps in early-stage life sciences by leveraging the deep domain expertise of its co-founders, investing in pre-seed to Series B rounds across various ophthalmic applications.

Industry: Investors

Partnerships

i-Pharm Consulting (talent partnership)The Glaucoma Foundation (capital partner)

Beyond the preview

Go deeper on ExSight Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExSight Ventures.

Explore the full profile